Yes, atrial fibrillation and ventricular tachycardia can occur at the same time. This is sometimes called “dual tachyarrhythmia,” a situation where the upper and lower chambers of the heart are each firing in their own chaotic or rapid rhythms independently. It’s uncommon, but it’s well documented in medical literature and tends to occur in people with significant underlying heart disease.
How Two Arrhythmias Can Coexist
To understand how this happens, it helps to know that the atria (upper chambers) and ventricles (lower chambers) can develop their own independent electrical problems. Normally, an electrical signal starts in the upper chambers and travels down to the ventricles through a relay point called the AV node. In AFib, the atria fire hundreds of disorganized signals per minute. In VTach, a separate circuit or focus in the ventricles fires rapidly on its own.
When VTach takes over the ventricles, it essentially disconnects them from whatever the atria are doing. The ventricles are now marching to their own beat. Meanwhile, the atria can continue fibrillating independently above. The two rhythms coexist because they’re operating in electrically separate territories. This is called “AV dissociation,” where the upper and lower chambers beat at different rates with no coordination between them.
Several biological mechanisms make this possible. Abnormal automaticity, where heart cells that normally stay quiet begin generating their own impulses, can create a self-sustaining focus in the ventricles. Reentry circuits, where electrical signals loop repeatedly through a small patch of damaged tissue, can independently drive either the atrial or ventricular rhythm. In some cases, a region of damaged or scarred heart muscle creates what’s known as a parasystolic focus: a pocket of cells that is shielded from the heart’s normal electrical signals but can still send its own impulses outward. These mechanisms can run simultaneously in different parts of the heart.
Conditions That Raise the Risk
Dual tachyarrhythmia doesn’t typically happen in an otherwise healthy heart. It’s most often seen in people with structural heart disease. Hypertrophic cardiomyopathy (HCM), a condition where the heart muscle is abnormally thick, is one well-documented example. In patients with HCM, atrial tachyarrhythmias with fast ventricular rates can actually trigger ventricular fibrillation or VTach. The mechanism likely involves a mismatch between the heart muscle’s oxygen demand and supply: the rapid atrial rate drives the ventricles too fast, starving the thickened muscle of oxygen and setting up conditions for a dangerous ventricular rhythm to ignite.
Other conditions associated with both arrhythmias include coronary artery disease (especially after a heart attack, which leaves scar tissue), dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and severe heart failure. Essentially, any condition that damages or remodels heart tissue in both the atria and ventricles creates fertile ground for independent arrhythmias to develop in each chamber.
What It Feels Like
The symptoms depend heavily on which rhythm is dominating and how fast the heart is beating. Some episodes of VTach are hemodynamically stable, meaning blood pressure holds up reasonably well and the person remains conscious, though they’ll typically feel palpitations, lightheadedness, or chest discomfort. Other episodes cause a rapid, dangerous drop in blood pressure, leading to near-syncope or full loss of consciousness within seconds.
When AFib and VTach overlap, the situation tends to be more hemodynamically severe than either rhythm alone. The loss of coordinated atrial contraction (from AFib) combined with the rapid, inefficient pumping of the ventricles (from VTach) means cardiac output can plummet. Symptoms can include sudden dizziness, shortness of breath, chest pressure, confusion, and collapse. In the case report from a patient with HCM, the dual tachyarrhythmia progressed to cardiac arrest requiring defibrillation.
Why It’s Hard to Spot on an EKG
Identifying concurrent AFib and VTach on a standard EKG is tricky, partly because the two rhythms can mimic other conditions. The key diagnostic challenge is distinguishing true VTach from “AFib with aberrancy,” which is AFib where the electrical signals travel through the ventricles along an abnormal path, producing wide, VTach-like complexes on the monitor.
A few features help clinicians tell them apart. In AFib with a bundle branch block, the rhythm is irregular (classic AFib pattern) but the wide QRS complexes all look the same from beat to beat. In AFib with multiple aberrant pathways, you’ll see several different QRS shapes. True VTach, by contrast, typically produces a regular, fast rhythm with a consistent wide QRS pattern. When both rhythms are present simultaneously, the EKG may show a fast, wide-complex ventricular rhythm that is regular (the VTach component) with no discernible atrial activity, or it may show brief transitions between the two rhythms. Implantable devices like pacemakers or defibrillators with dual-chamber sensing can record atrial and ventricular activity separately, making it easier to confirm both rhythms are happening at once.
How It’s Treated
Treatment priority always goes to whichever rhythm is more immediately dangerous, and that’s almost always the VTach. If the person is hemodynamically unstable, showing signs of low blood pressure, altered consciousness, or shock, the standard approach is synchronized cardioversion: a controlled electrical shock timed to the heart’s rhythm to reset it. This is part of the standard emergency protocol for any unstable tachycardia.
If the patient is stable enough to tolerate medication, antiarrhythmic drugs that work on both atrial and ventricular tissue may be used. Amiodarone is one of the most commonly chosen options in this scenario because it affects electrical conduction in both the atria and ventricles. Procainamide is another option that can slow conduction and extend the refractory period in atrial tissue while also being effective against VTach. The choice depends on the clinical situation, the patient’s underlying heart condition, and which rhythms persist after initial treatment.
Long-term management focuses on the underlying heart disease. Many patients with both arrhythmias end up with an implantable cardioverter-defibrillator (ICD), which continuously monitors heart rhythm and can deliver a shock internally if VTach or ventricular fibrillation recurs. Catheter ablation, a procedure that destroys the small areas of heart tissue responsible for generating abnormal signals, may be used to target either the AFib triggers, the VTach circuit, or both. Ongoing medication to suppress arrhythmias and manage the structural heart disease rounds out the treatment plan.
AFib Triggering VTach
One of the more important clinical findings is that AFib doesn’t just coexist passively with VTach. It can directly cause it. In patients with HCM, AFib at the time of defibrillator implantation is an independent risk factor for later needing a life-saving shock from the device. The proposed mechanism is straightforward: AFib drives the ventricles at a rapid rate, the thickened or diseased heart muscle can’t keep up with its own oxygen needs at that speed, and the resulting ischemia sets off a ventricular arrhythmia. This pathway has been implicated as one explanation for why AFib is associated with sudden cardiac death in certain high-risk populations, not because AFib itself is lethal, but because it can light the fuse for a rhythm that is.